Prostaglandin E1 Increases in vivo and in vitro calcitriol biosynthesis in rabbits

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 75, Issue 2, 2006, Pages 107-115

  Velasquez Forero F ^a   Garcia P ^a   Triffitt, J T ^a   Llach, F ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIFEDIOL; CALCITONIN; CALCITRIOL; CALCIUM; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; PROSTAGLANDIN E1; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BONE METABOLISM; CALCITONIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; INCUBATION TIME; KIDNEY PROXIMAL TUBULE; MALE; MINERAL BLOOD LEVEL; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RABBIT; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; ANIMAL; BLOOD; KINETICS;

ORYCTOLAGUS CUNICULUS;

ALPROSTADIL; ANIMALS; BIOLOGICAL MARKERS; CALCITRIOL; CALCIUM; KINETICS; MAGNESIUM; MALE; PHOSPHORUS; RABBITS;

EID: 33747814744     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.03.011     Document Type: Article

References (47)

1. Kraemer S., Meade E., and De witt D. Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch. Biochem. Biophys. 293 (1992) 391-400
2. Narumiya S., and Sugimoto Y. Prostanoid receptors: structures, properties and functions. Physiol. Rev. 79 (1999) 1193-1226
3. Pilbeam C., Harrison J., and Raisz L. Prostaglandins and Bone Metabolism. In: Bilezikian J.T., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology, chapter 51 (1996), Academic Press, New York, NY, USA 715-728
4. Coleman R., Kennedy I., Humphrey P., Bunce K., and Lumpley P. Prostanoids and their receptors. In: Emmett J.C. (Ed). Comprehensive Medicinal Chemistry, Membranes and Receptors vol. 3 (1990), Pergamon Press, Oxford, UK 643-714
5. Coleman R., Grix S., Head S., Louttit J., and Mallett A. A novel inhibitory receptor in piglet saphenous vein. Prostaglandins 47 (1994) 151-168
6. 2 receptor. Nature 349 (1991) 617-620
7. 1 subtype. J. Biol. Chem. 268 (1993) 26767-26772
8. 2 subtype. J. Biol. Chem. 269 (1994) 11873-11877
9. 3 receptors: evidence of three variants with differing carboxyl termini. Brit. J. Pharmacol. 112 (1994) 377-385
10. 4 receptor gene and related pseudogenes. Genomics 35 (1996) 182-188
11. L. Raisz, T. Martin, Prostaglandins in the bone and mineral metabolism, in: Bone and Mineral Research, annual 2, Excerp. Med., Amsterdam, 1983, pp. 286-310.
12. Rich T., Fagan K., Tse T., Schaack J., Cooper D., and Karpen J. A uniform extra cellular stimulus triggers distinct camp signals in different compartments of a simple cell. PNAS, USA 98 (2001) 13049-13054
13. Tomita M., Li X., Okada Y., Woodiel F., Young R., Pilbeam C., and Raisz L. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. Bone 30 (2002) 159-163
14. 2α on osteoclast formation in mouse bone marrow cultures. J. Bone. Miner. Res. 6 (1992) 157-164
15. Pilbeam C., Harrison J., and Raisz L. Prostaglandins and bone metabolism. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principle of Bone Biology (2002), Academic Press, London, UK 979-994
16. Choundhary S., Wadhwa S., Raisz L., Alander C., and Pilbeam C. Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathaway. J. Bone Miner. Res. 18 (2003) 1813-1824
17. Woo K., Emery J., and Peabody J. Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation. Pediatrics 93 (1994) 417-420
18. 2 alleviates cyclosporine a-induced bone loss in the rat. J. Bone Min. Res. 7 (1992) 1191-1200
19. 2 Signal through EP2 Promotes the Growth of articular chondrocytes. J. Bone Miner. Res. 20 (2005) 377-389
20. Portale A., and Miller W. Human 25-hydroxyvitamin d-1α-hydroxylase: cloning, mutations and gene expression. Pediatr. Nephrol. 14 (2000) 620-625
21. Heaney R., Recker R., and Saville P. Calcium balance and calcium requirements in middle-aged women. Am. J. Clin. Nutr. 30 (1977) 1603-1611
22. Halloran B., and Spencer E. Dietary phosphorus and 1,25dihydroxyvitamin D metabolism: influence of insulin-like growth factor I. Endocrinol 123 (1988) 1225-1229
23. 3 production in aging does not involve protein kinase A or C pathways. J. Bon. Miner. Res. 9 (1994) 339-345
24. 3 production by human keratinocytes. J. Clin. Invest. 78 (1986) 557-566
25. Insogna K., Dreyer B., Mitnick M., Ellison A., and Broadus A. Enhanced production rate of 1,25-dihydroxyvitamin D in sarcoidosis. J. Clin. Endocrinol. Metab. 66 (1988) 72-75
26. 3 synthesis by human placenta in culture. Mol. Hum. Reprod. 5 (1999) 771-776
27. 3 in primary chick kidney cell culture. Biochem. Biophys. Res. Comm. 9 (1980) 1210-1216
28. 2, furosemide and acetylsalicylic acid. Clin. Sci. 61 (1981) 53-59
29. Restrepo R., Welch T., Hug G., Clark K., and Bergstrom W. Hypercalciuria with Bartter's syndrome: evidence for an abnormality of vitamin D metabolism. J. Pediat. (1989) 397-404
30. Welch T. The hyperprostaglandin E syndrome: a hypercalciuric variant of Bartter's syndrome. J. Bone Miner. Res. 2 (1997) 1753
31. 2 correlation in children with idiopathic hypercalciuria, [abstract]. Prostaglandins Leukot. Essent. Fatty Acids 56 (1997) 235-237
32. 1, shortens the mineralization lag time in cat's palatine bone disjunction, histomorphometric study [abstract]. J. Bone. Miner. Res. 9 (1994) B484
33. 1 shortens the bone mineralization lag time in the rabbit disjunction palate [abstract]. J. Bone. Miner. Res. 9 (2000) 811
34. Aluja S., Cortés A., Pinzón E., Lomelí F., and Frenk S. La experimentación científica en animales. Gac. Méx. 123 (1987) 247-259
35. 1 in man. J. Clin. Invest. 56 (1975) 1404
36. Gutman A.B. Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. Am. J. Med. 27 (1959) 875
37. Calvo M., Eyre D., and Gundberg C. Molecular basis and clinical application of biological markers of bone turnover. Endocrine Rev. 17 (1996) 333-368
38. Vinay P., Gougoux A., and Lemieux G. Isolation of a pure suspension of rat proximal tubules. Am. Physiol. Soc. (1981) F403-F411
39. 3 net synthesis by rat proximal tubules. J. Lab. Clin. Med. 106 (1985) 286-292
40. Jacobsen N., Jorgensen F., and Thomsen A. On the localization of some phosphatases in three different segments of the proximal tubules in the rat kidney. J. Histochem. Cytochem. 15 (1967) 456-468
41. 2 receptor antagonist. Biochem. Pharmacol. 50 (1995) 1731-1733
42. Crider J., Griffin B., and Sharif N. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. Brit. J. Pharmacol. 127 (1999) 204-210
43. R. Rude, Magnesium deficiency and hypermagnesemia, in: J.M. Favus (Ed.), Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 2nd ed., Raven Press, New York, NY, USA, 1993, p. 210 (Chapter 54).
44. 2 on cancellous and cortical bone in young adult dogs. Bone 11 (1990) 353-364
45. Engesaeter L.B., Sudmann B., and Sudmann E. Fracture healing in rats inhibited by locally administered indomethacin. Acta. Orthop. Scand. 63 (1992) 330-333
46. Makibayashi K., Tatemasu M., Hirata M., et al. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am. J. Pathol. 158 (2001) 1733-1741
47. 3 on primary cultures of human prostatic cells. Cancer Res. 54 (1994) 805-810